These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38334646)

  • 1. Characterization of pSer129-αSyn Pathology and Neurofilament Light-Chain Release across In Vivo, Ex Vivo, and In Vitro Models of Pre-Formed-Fibril-Induced αSyn Aggregation.
    Hansen ML; Ambjørn M; Harndahl MN; Benned-Jensen T; Fog K; Bjerregaard-Andersen K; Sotty F
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein aggregates are phosphatase resistant.
    Choi SG; Tittle T; Garcia-Prada D; Kordower JH; Melki R; Killinger BA
    Acta Neuropathol Commun; 2024 May; 12(1):84. PubMed ID: 38822421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
    Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
    Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex.
    Boutros SW; Raber J; Unni VK
    J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo.
    Wu Q; Shaikh MA; Meymand ES; Zhang B; Luk KC; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2020 Dec; 140(6):831-849. PubMed ID: 33021680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
    Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
    Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein aggregates are phosphatase resistant.
    Choi SG; Tittle T; Garcia-Prada D; Kordower JH; Melki R; Killinger BA
    bioRxiv; 2024 Apr; ():. PubMed ID: 38645137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration.
    Wang X; Becker K; Levine N; Zhang M; Lieberman AP; Moore DJ; Ma J
    Acta Neuropathol Commun; 2019 Mar; 7(1):41. PubMed ID: 30871620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy.
    Walton S; Fenyi A; Tittle T; Sidransky E; Pal G; Choi S; Melki R; Killinger BA; Kordower JH
    NPJ Parkinsons Dis; 2024 May; 10(1):105. PubMed ID: 38773124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antibodies to phosphorylated α-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes.
    Rutherford NJ; Brooks M; Giasson BI
    Acta Neuropathol Commun; 2016 Aug; 4(1):80. PubMed ID: 27503460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.
    Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM
    J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-Synucleinopathies.
    Imarisio A; Ferrari E; Pilotto A; Di Luca M; Padovani A; Gardoni F
    Neurodegener Dis; 2022; 22(1):7-14. PubMed ID: 35940118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neither alpha-synuclein-preformed fibrils derived from patients with
    Walton S; Fenyi A; Tittle T; Sidransky E; Pal G; Choi S; Melki R; Killinger BA; Kordower JH
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.
    Hinkle JT; Patel J; Panicker N; Karuppagounder SS; Biswas D; Belingon B; Chen R; Brahmachari S; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2118819119. PubMed ID: 35394877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial inclusions and neurofilament light chain release follow neuronal α-synuclein lesions in long-term brain slice cultures.
    Barth M; Bacioglu M; Schwarz N; Novotny R; Brandes J; Welzer M; Mazzitelli S; Häsler LM; Schweighauser M; Wuttke TV; Kronenberg-Versteeg D; Fog K; Ambjørn M; Alik A; Melki R; Kahle PJ; Shimshek DR; Koch H; Jucker M; Tanriöver G
    Mol Neurodegener; 2021 Aug; 16(1):54. PubMed ID: 34380535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function.
    Creed RB; Memon AA; Komaragiri SP; Barodia SK; Goldberg MS
    Acta Neuropathol Commun; 2022 May; 10(1):78. PubMed ID: 35606853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration.
    Singh A; Panhelainen A; Voutilainen MH
    Neurosci Lett; 2023 Nov; 816():137510. PubMed ID: 37802418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
    Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
    Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.